CytoDyn HIV Indication Update: Leronlimab HIV Extension Arm Nearing 7 Years with Continued Excellent Safety ResultsGlobeNewsWire • 05/03/21
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages CytoDyn Inc. Investors with Losses to Secure Counsel Before Important May 17 Deadline in Securities Class Action – CYDYBusiness Wire • 05/02/21
Class Action Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds CytoDyn Inc. Investors of Deadline in Securities Fraud Class Action LawsuitNewsfile Corp • 05/01/21
ROSEN, A TOP RANKED LAW FIRM, Encourages CytoDyn Inc. Investors With Losses over $100K to Secure Counsel Before Important May 17 Deadline in Securities Class Action - CYDYNewsfile Corp • 04/29/21
CYDY INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against CytoDyn Inc.PRNewsWire • 04/27/21
CytoDyn's Chief Medical Officer Dr. Scott Kelly to Present at Triple Negative Breast Cancer Drug Development Digital Summit 2021 on April 28GlobeNewsWire • 04/27/21
Rosen, Nationally Regarded Investor Counsel, Encourages CytoDyn Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CYDYNewsfile Corp • 04/26/21
Shareholder Alert: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of CytoDyn Inc. of Securities Class Action LawsuitNewsfile Corp • 04/23/21
CytoDyn raises another $25M for Vyrologix development in second covertable debt offering this monthProactive Investors • 04/23/21
CytoDyn Completes $28.5 Million Convertible Note Financing with Conversion Rate at $10.00 Per Share Without WarrantsGlobeNewsWire • 04/23/21
Investor Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against CytoDyn Inc. (CYDY)PRNewsWire • 04/21/21
Robbins Geller Rudman & Dowd LLP Announces Lead Plaintiff Deadline in the CytoDyn, Inc. Class Action LawsuitBusiness Wire • 04/21/21
CYTODYN, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New YorkPRNewsWire • 04/20/21
CYDY INVESTOR ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages CytoDyn Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CYDYPRNewsWire • 04/20/21
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CytoDyn, Inc. (CYDY)PRNewsWire • 04/19/21
Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against CytoDyn Inc.Newsfile Corp • 04/19/21
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against CytoDyn Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the FirmPRNewsWire • 04/19/21
CytoDyn submits manufacturing section of interim order application for leronlimab as coronavirus treatment to Health CanadaProactive Investors • 04/19/21
CytoDyn Submits First and Most Crucial Section (CMC) of Interim Order Application to Health Canada for COVID-19 Under Rolling ReviewGlobeNewsWire • 04/19/21
Former President of the Philippines, Joseph Estrada, Among the Many COVID-19 Patients Receiving Leronlimab Under CSP in the PhilippinesGlobeNewsWire • 04/19/21
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Against CytoDyn Inc.Newsfile Corp • 04/17/21
CytoDyn strikes agreement with Chiral Pharma to supply up to 200K vials of leronlimab to critically ill coronavirus patients in the PhilippinesProactive Investors • 04/15/21
CytoDyn Executes Exclusive Supply and Distribution Agreement with Chiral Pharma Corporation to Provide Up to 200,000 vials of Leronlimab to PhilippinesGlobeNewsWire • 04/15/21
CYDY CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds CytoDyn Inc. Shareholders of Securities Fraud Class Action LawsuitNewsfile Corp • 04/14/21
CYDY Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds CytoDyn, Inc. Investors With Losses Exceeding $100K of Class Action and Encourages Shareholders to Contact the FirmBusiness Wire • 04/13/21
